4-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile

(R)-4-((6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile benzoate

Pharmaceutical intermediate for alogliptin

Alogliptin Impurity 70

pharmaceutical intermediate for alogliptin

Sulfonium, triphenyl-, alfa,alfa,beta,beta-tetrafluorohexahydrospiro[4,7-methano-1,3-benzodioxole-2,2a(2)-tricyclo[3.3.1.13,7]decane]-5-ethanesulfonate

Photoacid generator for cationic polymerization

[(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-30-[4-[[4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methoxycarbonylamino]piperidin-1-yl]-2,6,15,17-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-23,32,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1,3,5,9,19,21,25,28,30,33,35-undecaen-13-yl] acetate

research compound

Bis [2- (2,4-difluorophenyl) -5-trifluoromethylpyridine] [1,10-phenanthroline] iridium hexafluorophosphate

research compound

N-Acetyl-L-prolinamide

peptide building block

Trelagliptina

active pharmaceutical ingredient

TRELAGLIPTIN SUCCINATE

active pharmaceutical ingredient